Barinthus Biotherapeutics plc (NASDAQ: BRNS)
$1.0750
+0.0550 ( +2.38% ) 12.3K
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
Market Data
Open
$1.0750
Previous close
$1.0200
Volume
12.3K
Market cap
$43.13M
Day range
$0.9860 - $1.1050
52 week range
$0.8008 - $4.1591
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 47 | May 13, 2024 |
| 10-q | Quarterly Reports | 75 | May 13, 2024 |
| 8-k | 8K-related | 16 | Apr 18, 2024 |
| def | Proxies and info statements | 14 | Mar 22, 2024 |
| ars | Annual reports | 1 | Mar 22, 2024 |
| 10-k | Annual reports | 121 | Mar 20, 2024 |
| 8-k | 8K-related | 16 | Mar 20, 2024 |
| 8-k | 8K-related | 17 | Jan 05, 2024 |
| 4 | Insider transactions | 1 | Jan 04, 2024 |
| 4 | Insider transactions | 1 | Jan 04, 2024 |